Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Complications of nephrotic syndrome

  • Park, Se-Jin (Department of Pediatrics, Ajou University Hospital, Ajou University School of Medicine) ;
  • Shin, Jae-Il (The Institute of Kidney Disease, Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine)
  • Received : 2011.06.21
  • Accepted : 2011.08.07
  • Published : 2011.08.15
Download PDF
⟨ Previous Next ⟩

Abstract

Nephrotic syndrome (NS) is one of the most common glomerular diseases that affect children. Renal histology reveals the presence of minimal change nephrotic syndrome (MCNS) in more than 80% of these patients. Most patients with MCNS have favorable outcomes without complications. However, a few of these children have lesions of focal segmental glomerulosclerosis, suffer from severe and prolonged proteinuria, and are at high risk for complications. Complications of NS are divided into two categories: disease-associated and drug-related complications. Disease-associated complications include infections (e.g., peritonitis, sepsis, cellulitis, and chicken pox), thromboembolism (e.g., venous thromboembolism and pulmonary embolism), hypovolemic crisis (e.g., abdominal pain, tachycardia, and hypotension), cardiovascular problems (e.g., hyperlipidemia), acute renal failure, anemia, and others (e.g., hypothyroidism, hypocalcemia, bone disease, and intussusception). The main pathomechanism of disease-associated complications originates from the large loss of plasma proteins in the urine of nephrotic children. The majority of children with MCNS who respond to treatment with corticosteroids or cytotoxic agents have smaller and milder complications than those with steroid-resistant NS. Corticosteroids, alkylating agents, cyclosporin A, and mycophenolate mofetil have often been used to treat NS, and these drugs have treatment-related complications. Early detection and appropriate treatment of these complications will improve outcomes for patients with NS.

Keywords

References

  1. Ulinski T, Aoun B. Pediatric idiopathic nephrotic syndrome: treatment strategies in steroid dependent and steroid resistant forms. Curr Med Chem 2010;17:847-53. https://doi.org/10.2174/092986710790712174
  2. Schrier RW, Gottschalk CW. Diseases of the Kidney. 4th ed. Boston: Little, Brown, 1988;1749, 1899.
  3. Davison AM, Cameron JS, Grunfeld JP, Ponticelli C, Ritz E, Winearls CG, et al. Oxford textbook of clinical nephrology. 3rd ed. New York: Oxford University Press, 2005;421.
  4. Gulati S, Kher V, Gulati K, Arora P, Gujral R. Tuberculosis in childhood nephrotic syndrome in India. Pediatr Nephrol 1997;11:695-8.
  5. Gorensek MJ, Lebel MH, Nelson JD. Peritonitis in children with nephrotic syndrome. Pediatrics 1988;81:849-56.
  6. Latta K, von Schnakenburg C, Ehrich JH. A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 2001;16:271-82. https://doi.org/10.1007/s004670000523
  7. Tain YL, Lin G, Cher TW. Microbiological spectrum of septicemia and peritonitis in nephrotic children. Pediatr Nephrol 1999;13:835-7. https://doi.org/10.1007/s004670050710
  8. Kliegman RM, Behrman RE, Jenson HB, Stanton BF. Nelson textbook of pediatrics. 18th ed. Philadelphia: Saunders, 2007;2193-4.
  9. Tejani A, Fikrig S, Schiffman G, Gurumurthy K. Persistence of protective pneumococcal antibody following vaccination in patients with the nephrotic syndrome. Am J Nephrol 1984;4:32-7. https://doi.org/10.1159/000166769
  10. Alpay H, Yildiz N, Onar A, Temizer H, Ozçay S. Varicella vaccination in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 2002;17:181-3. https://doi.org/10.1007/s00467-001-0789-7
  11. Kato S, Chernyavsky S, Tokita JE, Shimada YJ, Homel P, Rosen H, et al. Relationship between proteinuria and venous thromboembolism. J Thromb Thrombolysis 2010;30:281-5. https://doi.org/10.1007/s11239-010-0442-z
  12. Ulinski T, Guigonis V, Baudet-Bonneville V, Auber F, Garcette K, Bensman A. Mesenteric thrombosis causing short bowel syndrome in nephrotic syndrome. Pediatr Nephrol 2003;18:1295-7. https://doi.org/10.1007/s00467-003-1281-3
  13. Cade R, Spooner G, Juncos L, Fuller T, Tarrant D, Raulerson D, et al. Chronic renal vein thrombosis. Am J Med 1977;63:387-97. https://doi.org/10.1016/0002-9343(77)90277-7
  14. Rabelink TJ, Zwaginga JJ, Koomans HA, Sixma JJ. Thrombosis and hemostasis in renal disease. Kidney Int 1994;46:287-96. https://doi.org/10.1038/ki.1994.274
  15. Llach F. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int 1985;28:429-39. https://doi.org/10.1038/ki.1985.149
  16. Lau SO, Tkachuck JY, Hasegawa DK, Edson JR. Plasminogen and antithrombin III deficiencies in the childhood nephrotic syndrome associated with plasminogenuria and antithrombinuria. J Pediatr 1980;96(3 Pt 1):390-2. https://doi.org/10.1016/S0022-3476(80)80678-0
  17. Ozsoylu S, Strauss HS, Diamond LK. Effects of corticosteroids on coagulation of the blood. Nature 1962;195:1214-5. https://doi.org/10.1038/1951214a0
  18. Lilova MI, Velkovski IG, Topalov IB. Thromboembolic complications in children with nephrotic syndrome in Bulgaria (1974-1996). Pediatr Nephrol 2000;15:74-8. https://doi.org/10.1007/s004679900253
  19. Witz M, Korzets Z. Renal vein occlusion: diagnosis and treatment. Isr Med Assoc J 2007;9:402-5.
  20. Huang J, Yang J, Ding J. Pulmonary embolism associated with nephrotic syndrome in children: a preliminary report of 8 cases. Chin Med J (Engl) 2000;113:251-3.
  21. Lechner BL, Bockenhauer D, Iragorri S, Kennedy TL, Siegel NJ. The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome. Pediatr Nephrol 2004;19:744-8. https://doi.org/10.1007/s00467-004-1460-x
  22. Zilleruelo G, Hsia SL, Freundlich M, Gorman HM, Strauss J. Persistence of serum lipid abnormalities in children with idiopathic nephrotic syndrome. J Pediatr 1984;104:61-4. https://doi.org/10.1016/S0022-3476(84)80590-9
  23. Appel GB, Blum CB, Chien S, Kunis CL, Appel AS. The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity. N Engl J Med 1985;312:1544-8. https://doi.org/10.1056/NEJM198506133122404
  24. Prescott WA Jr, Streetman DA, Streetman DS. The potential role of HMG-CoA reductase inhibitors in pediatric nephrotic syndrome. Ann Pharmacother 2004;38:2105-14. https://doi.org/10.1345/aph.1D587
  25. Bruckert E, Hayem G, Dejager S, Yau C, Begaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study. Cardiovasc Drugs Ther 2005;19:403-14. https://doi.org/10.1007/s10557-005-5686-z
  26. Baer AN, Wortmann RL. Myotoxicity associated with lipid-lowering drugs. Curr Opin Rheumatol 2007;19:67-73.
  27. Wang SJ, Tsau YK, Lu FL, Chen CH. Hypovolemia and hypovolemic shock in children with nephrotic syndrome. Acta Paediatr Taiwan 2000;41:179-83.
  28. Donckerwolcke RA, France A, Raes A, Vande Walle J. Distal nephron sodium-potassium exchange in children with nephrotic syndrome. Clin Nephrol 2003;59:259-66. https://doi.org/10.5414/CNP59259
  29. Matsumoto H, Miyaoka Y, Okada T, Nagaoka Y, Wada T, Gondo A, et al. Ratio of urinary potassium to urinary sodium and the potassium and edema status in nephrotic syndrome. Intern Med 2011;50:551-5. https://doi.org/10.2169/internalmedicine.50.4537
  30. Ellis D. Anemia in the course of the nephrotic syndrome secondary to transferrin depletion. J Pediatr 1977;90:953-5. https://doi.org/10.1016/S0022-3476(77)80567-2
  31. Vaziri ND. Erythropoietin and transferrin metabolism in nephrotic syndrome. Am J Kidney Dis 2001;38:1-8.
  32. Toubiana J, Schlageter MH, Aoun B, Dunand O, Vitkevic R, Bensman A, et al. Therapy-resistant anaemia in congenital nephrotic syndrome of the Finnish type--implication of EPO, transferrin and transcobalamin losses. Nephrol Dial Transplant 2009;24:1338-40.
  33. Agarwal N, Phadke KD, Garg I, Alexander P. Acute renal failure in children with idiopathic nephrotic syndrome. Pediatr Nephrol 2003;18:1289-92. https://doi.org/10.1007/s00467-003-1259-1
  34. Raij L, Keane WF, Leonard A, Shapiro FL. Irreversible acute renal failure in idiopathic nephrotic syndrome. Am J Med 1976;61:207-14. https://doi.org/10.1016/0002-9343(76)90171-6
  35. Lowenstein J, Schacht RG, Baldwin DS. Renal failure in minimal change nephrotic syndrome. Am J Med 1981;70:227-33. https://doi.org/10.1016/0002-9343(81)90754-3
  36. Vande Walle JG, Donckerwolcke RA. Pathogenesis of edema formation in the nephrotic syndrome. Pediatr Nephrol 2001;16:283-93. https://doi.org/10.1007/s004670000512
  37. Muranjan MN, Kher AS, Nadkarni UB, Kamat JR. Congenital nephrotic syndrome with clinical hypothyroidism. Indian J Pediatr 1995;62:233-5. https://doi.org/10.1007/BF02752333
  38. Goldstein DA, Haldimann B, Sherman D, Norman AW, Massry SG. Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function. J Clin Endocrinol Metab 1981;52:116-21. https://doi.org/10.1210/jcem-52-1-116
  39. Sato KA, Gray RW, Lemann J Jr. Urinary excretion of 25-hydroxyvitamin D in health and the nephrotic syndrome. J Lab Clin Med 1982;99:325- 30.
  40. Cho MH, Hwang HH, Choe BH, Kwon SH, Ko CW, Kim JY, et al. The reversal of intussusception associated with nephrotic syndrome by infusion of albumin. Pediatr Nephrol 2009;24:421-2. https://doi.org/10.1007/s00467-008-1019-3
  41. Hodson EM, Willis NS, Craig JC. Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev 2007;(4):CD001533.
  42. Grenda R, Webb NJ. Steroid minimization in pediatric renal transplantation: early withdrawal or avoidance? Pediatr Transplant 2010; 14:961-7. https://doi.org/10.1111/j.1399-3046.2010.01403.x
  43. Dong F, Ren J. Insulin-like growth factors (IGFs) and IGF-binding proteins in nephrotic syndrome children on glucocorticoid. Pharmacol Res 2003;48:319-23. https://doi.org/10.1016/S1043-6618(03)00182-8
  44. Zhou X, Loke KY, Pillai CC, How HK, Yap HK, Lee KO. IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH. Eur J Endocrinol 2001;144:237-43. https://doi.org/10.1530/eje.0.1440237
  45. Dong F, Zhou X, Pang N, Wei M. Effect of glucocorticoid treatment on insulin like growth factor-I and its binding proteins in children with nephrotic syndrome. Chin Med J (Engl) 2002;115:1383-5.
  46. Bernard DB. Extrarenal complications of the nephrotic syndrome. Kidney Int 1988;33:1184-202. https://doi.org/10.1038/ki.1988.129
  47. Abe T, Ichimaru N, Kakuta Y, Okumi M, Imamura R, Isaka Y, et al. Long-term outcome of pediatric renal transplantation: a single center experience. Clin Transplant 2011;25:388-94. https://doi.org/10.1111/j.1399-0012.2010.01250.x
  48. Jeon SH, Lim AY, Kim YK, Cheon HW, Yoo KH, Hong YS, et al. The effect of steroid therapy on growth and bone density in children with nephrotic syndrome. J Korean Pediatr Soc 1998;41:1396-1402.
  49. Hall AS, Thorley G, Houtman PN. The effects of corticosteroids on behavior in children with nephrotic syndrome. Pediatr Nephrol 2003;18:1220-3. https://doi.org/10.1007/s00467-003-1295-x
  50. Ueda N, Kuno K, Ito S. Eight and 12 week courses of cyclophosphamide in nephrotic syndrome. Arch Dis Child 1990;65:1147-50. https://doi.org/10.1136/adc.65.10.1147
  51. Truffa-Bachi P, Lefkovits I, Frey JR. Proteomic analysis of T cell activation in the presence of cyclosporin A: immunosuppressor and activator removal induces de novo protein synthesis. Mol Immunol 2000;37:21-8. https://doi.org/10.1016/S0161-5890(00)00026-2
  52. Chishti AS, Sorof JM, Brewer ED, Kale AS. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose. Am J Kidney Dis 2001;38:754-60. https://doi.org/10.1053/ajkd.2001.27692
  53. Bertani T, Perico N, Abbate M, Battaglia C, Remuzzi G. Renal injury induced by long-term administration of cyclosporin A to rats. Am J Pathol 1987;127:569-79.
  54. Kim JH, Park SJ, Yoon SJ, Lim BJ, Jeong HJ, Lee JS, et al. Predictive factors for ciclosporin-associated nephrotoxicity in children with minimal change nephrotic syndrome. J Clin Pathol 2011;64:516-9. https://doi.org/10.1136/jclinpath-2011-200005
  55. Iijima K, Hamahira K, Tanaka R, Kobayashi A, Nozu K, Nakamura H, et al. Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int 2002;61:1801-5. https://doi.org/10.1046/j.1523-1755.2002.00303.x
  56. Fujinaga S, Kaneko K, Muto T, Ohtomo Y, Murakami H, Yamashiro Y. Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome. Arch Dis Child 2006;91:666-70. https://doi.org/10.1136/adc.2005.080960
  57. Yang CW, Ahn HJ, Kim WY, Li C, Kim HW, Choi BS, et al. Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity. Kidney Int 2002;62:20-30. https://doi.org/10.1046/j.1523-1755.2002.00400.x
  58. Hara S, Umino D, Someya T, Fujinaga S, Ohtomo Y, Murakami H, et al. Protective effects of Mizoribine on Cyclosporine A nephropathy in rats. Pediatr Res 2009;66:524-7. https://doi.org/10.1203/PDR.0b013e3181b9b48a
  59. Aiyangar A, Rajput P, Shah BV. Mycophenolate induced diarrhoea. J Assoc Physicians India 2010;58:192-4.
  60. De Rycke A, Dierickx D, Kuypers DR. Tacrolimus-induced neutropenia in renal transplant recipients. Clin J Am Soc Nephrol 2011;6:690-4. https://doi.org/10.2215/CJN.07320810
  61. Bagga A, Sinha A, Moudgil A. Rituximab in patients with the steroidresistant nephrotic syndrome. N Engl J Med 2007;356:2751-2. https://doi.org/10.1056/NEJMc063706
  62. Gea-Banacloche JC. Rituximab-associated infections. Semin Hematol 2010;47:187-98. https://doi.org/10.1053/j.seminhematol.2010.01.002

Cited by

  1. Pulmonary embolism following isolated upper limb injury: a rare complication vol.3, pp.4, 2011, https://doi.org/10.1007/s12570-012-0126-6
  2. Disseminated cryptococcosis initially presenting as cellulitis in a patient suffering from nephrotic syndrome vol.14, pp.None, 2011, https://doi.org/10.1186/1471-2369-14-20
  3. Fatal embolic events in childhood vol.20, pp.1, 2011, https://doi.org/10.1016/j.jflm.2012.04.036
  4. A Case of Severe Influenza Infection in a Child with Nephrotic Syndrome on Steroid Therapy vol.18, pp.1, 2011, https://doi.org/10.3339/jkspn.2014.18.1.47
  5. Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy vol.19, pp.1, 2015, https://doi.org/10.1007/s10157-014-1031-9
  6. Primary Cutaneous Nocardiosis in a Patient With Nephrotic Syndrome : A Case Report and Review of the Literature vol.95, pp.3, 2016, https://doi.org/10.1097/md.0000000000002490
  7. Pathogenesis of minimal change nephrotic syndrome: an immunological concept vol.59, pp.5, 2011, https://doi.org/10.3345/kjp.2016.59.5.205
  8. A rare case of phaeohyphomycosis caused by Fonsecaea pedrosoi in a child with nephrotic syndrome vol.26, pp.3, 2011, https://doi.org/10.4103/0971-4065.165002
  9. Urinary potassium to urinary potassium plus sodium ratio can accurately identify hypovolemia in nephrotic syndrome: a provisional study vol.177, pp.1, 2018, https://doi.org/10.1007/s00431-017-3029-2
  10. Abdominal involvement in minimal change nephrotic syndrome vol.22, pp.2, 2011, https://doi.org/10.1007/s10157-017-1446-1
  11. Necrotizing fasciitis in nephritic syndrome: a case report vol.125, pp.None, 2011, https://doi.org/10.1088/1755-1315/125/1/012072
  12. A typical 22q11.2 deletion syndrome and pseudohypoparathyroidism : A CARE compliant case report vol.98, pp.25, 2011, https://doi.org/10.1097/md.0000000000016109
  13. Bioimpedance Resistance Indices and Cell Membrane Capacitance Used to Assess Disease Status and Cell Membrane Integrity in Children with Nephrotic Syndrome vol.2019, pp.None, 2011, https://doi.org/10.1155/2019/4274856
  14. Safety and Efficacy of Pneumococcal Vaccination in Pediatric Nephrotic Syndrome vol.7, pp.None, 2011, https://doi.org/10.3389/fped.2019.00339
  15. Bone Health in Glomerular Kidney Disease vol.17, pp.6, 2011, https://doi.org/10.1007/s11914-019-00531-z
  16. Clinical significance of IgM deposition in pediatric minimal change disease vol.6, pp.4, 2019, https://doi.org/10.1016/j.ijpam.2019.09.001
  17. Evaluation the Efficacy of Vitamin D Consumption on Nephrotic Syndrome Condition in Children: A Clinical Trial Study vol.12, pp.1, 2020, https://doi.org/10.5812/numonthly.97001
  18. Efficacy and safety of tacrolimus and low-dose prednisone in Chinese children with steroid-resistant nephrotic syndrome vol.16, pp.2, 2011, https://doi.org/10.1007/s12519-019-00257-z
  19. Augmentation index, a predictor of cardiovascular events, is increased in children and adolescents with primary nephrotic syndrome vol.35, pp.5, 2020, https://doi.org/10.1007/s00467-019-04434-0
  20. Nephrotic syndrome‐associated hypercoagulopathy is alleviated by both pioglitazone and glucocorticoid which target two different nuclear receptors vol.8, pp.15, 2011, https://doi.org/10.14814/phy2.14515
  21. The clinical characteristic and outcome of skin and soft tissue infection in immunosuppressive patients with nephrotic syndrome vol.24, pp.9, 2011, https://doi.org/10.1007/s10157-020-01893-w
  22. Pierson Syndrome Associated with Hypothyroidism and Septic Shock vol.20, pp.4, 2011, https://doi.org/10.18295/squmj.2020.20.04.017
  23. Non-infective supraglottitis: two cases of unusual aetiology vol.13, pp.12, 2011, https://doi.org/10.1136/bcr-2020-238664
  24. A cross-sectional nationwide survey of congenital and infantile nephrotic syndrome in Japan vol.21, pp.1, 2011, https://doi.org/10.1186/s12882-020-02010-5
  25. Relationship between Serum 25(OH)D Levels and Blood Pressure in Children with Nephrotic Syndrome vol.9, pp.2, 2020, https://doi.org/10.3889/oamjms.2021.5672
  26. Pediatric Nephrotic Syndrome: Pharmacologic and Nutrition Management vol.36, pp.2, 2011, https://doi.org/10.1002/ncp.10622
  27. 57-Year-Old Woman With Fatigue and Lower-Extremity Edema vol.96, pp.6, 2011, https://doi.org/10.1016/j.mayocp.2020.09.044
  28. A Novel Model for Nephrotic Syndrome Reveals Associated Dysbiosis of the Gut Microbiome and Extramedullary Hematopoiesis vol.10, pp.6, 2011, https://doi.org/10.3390/cells10061509